Source: International Congress 2019 – Tuberculosis and comorbidities
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Kaptan (Izmir, Turkey), A. Sunel (Izmir, Turkey), M. Tas (Izmir, Turkey), F. Oksel (Izmir, Turkey), K. Aksu (Izmir, Turkey), A. Sayiner (Izmir, Turkey). Risk Factors for tuberculosis in patients on anti-TNF treatment. 2974

Member's Comments

No comment yet.

Related content which might interest you: Risk factors for anti-tuberculosis treatment failure Source: Annual Congress 2011 - Tuberculosis epidemiology and public health Year: 2011 Risk factors for relapses of tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 345s Year: 2003 Risk factors of hepatotoxicity during tuberculosis treatment and management Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis I Year: 2008 Factors affecting the efficacy of treatment of MDR/XDR TB patients receiving bedaquiline Source: International Congress 2019 – Tuberculosis: a public health approach Year: 2019 Risk of tuberculosis in pediatric patients treated with biological agents Source: Virtual Congress 2020 – Aspects of acute and chronic airway infections in children Year: 2020 Risk factors for tuberculosis in patients with chronic alcoholism Source: Virtual Congress 2021 – Epidemiological aspects of tuberculosis Year: 2021 Factors associated with completion of tuberculosis treatment Source: Eur Respir J 2005; 26: Suppl. 49, 428s Year: 2005 Risk factors for extrapulmonar tuberculosis Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings Year: 2012 Anti-TNF-alpha therapy in patients with latent tuberculosis incidence Source: International Congress 2015 – Screening strategies in TB Year: 2015 Risk factors for tuberculosis relapse in Polish patients Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013 Risk of serious adverse reactions during the treatment of new tuberculosis patients Source: Annual Congress 2012 - Tuberculosis: clinical findings II Year: 2012 Latent tuberculosis infection prevalence and risk of developing active TB among patients eligible for starting anti-TNFα therapy Source: International Congress 2015 – Screening strategies in TB Year: 2015 Treatment interruptions in patients with MDR/XDR-TB: risk factors and impact on treatment outcomes Source: International Congress 2016 – Drug-resistant tuberculosis and experiences with delamanid and bedaquiline Year: 2016 Predictors of defaulting from treatment among patients with tuberculosis Source: International Congress 2015 – Management of TB: a patient focus Year: 2015 Risk factors associated with treatment interruption for 2 months among tuberculosis patients in Taipei Source: Annual Congress 2007 - Tuberculosis control Year: 2007 Factors affecting tuberculosis treatment: the beliefs of patients Source: Eur Respir J 2005; 26: Suppl. 49, 649s Year: 2005 Risk factors for antibiotic re-administration in patients with pneumonia during hospitalization. Source: International Congress 2018 – Improving the outcomes of community-acquired pneumonia Year: 2018 Study of risk factors in relapses at patients with pulmonary tuberculosis. Their retreatment results Source: Eur Respir J 2001; 18: Suppl. 33, 467s Year: 2001 Incidence of tuberculosis among anti-TNF users in patients with previous history of tuberculosis Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management III Year: 2013 Risk factors for discontinuation of roflumilast in COPD patients Source: International Congress 2017 – COPD management Year: 2017